Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
The Journal of Infectious Diseases
|
November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia
Melissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Journal of Paediatrics and Child Health
|
April 1, 1996
Late-onset infections of infants in neonatal units
D Isaacs, C Barfield, T Clothier, et al.
Lancet (London, England)
|
July 11, 2001
Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial
G Lawrence, D Tudehope, K Baumann, et al.
Journal of the American Chemical Society
|
September 2, 2025
Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
Anna Lechner, Peter A Jordan, Gabriella Costa Machado da Cruz, et al.
Chem
|
February 12, 2026
Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipients
Naxhije Berisha, Atena Farahpour, Maithreyi Ramakrishnan, et al.
Journal of Virology
|
June 15, 2007
Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions
Erin E Verity, Dimitra Zotos, Kim Wilson, et al.
Nature Materials
|
September 15, 2020
Mechanistic insights of evaporation-induced actuation in supramolecular crystals
Roxana Piotrowska, Travis Hesketh, Haozhen Wang, et al.
Veterinary Microbiology
|
April 1, 1983
Serological studies of Australian and Papua New Guinean cattle and Australian sheep for the presence of antibodies against bluetongue group viruses
A J Della-Porta, R F Sellers, K A Herniman, et al.
HIV Clinical Trials
|
April 30, 2004
A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals
Sarah L Pett, Lisa A Williams, Richard O Day, et al.
Clinical Immunology (Orlando, Fla.)
|
August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders
Alex Padiglione, Eman Aleksic, Martyn French, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
The Journal of Infectious Diseases
|
November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia
Melissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Journal of Paediatrics and Child Health
|
April 1, 1996
Late-onset infections of infants in neonatal units
D Isaacs, C Barfield, T Clothier, et al.
Lancet (London, England)
|
July 11, 2001
Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial
G Lawrence, D Tudehope, K Baumann, et al.
Journal of the American Chemical Society
|
September 2, 2025
Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
Anna Lechner, Peter A Jordan, Gabriella Costa Machado da Cruz, et al.
Chem
|
February 12, 2026
Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipients
Naxhije Berisha, Atena Farahpour, Maithreyi Ramakrishnan, et al.
Journal of Virology
|
June 15, 2007
Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions
Erin E Verity, Dimitra Zotos, Kim Wilson, et al.
Nature Materials
|
September 15, 2020
Mechanistic insights of evaporation-induced actuation in supramolecular crystals
Roxana Piotrowska, Travis Hesketh, Haozhen Wang, et al.
Veterinary Microbiology
|
April 1, 1983
Serological studies of Australian and Papua New Guinean cattle and Australian sheep for the presence of antibodies against bluetongue group viruses
A J Della-Porta, R F Sellers, K A Herniman, et al.
HIV Clinical Trials
|
April 30, 2004
A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals
Sarah L Pett, Lisa A Williams, Richard O Day, et al.
Clinical Immunology (Orlando, Fla.)
|
August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders
Alex Padiglione, Eman Aleksic, Martyn French, et al.
Page
of 10